I am glad to see MST have put out a report that matches our clinical development plan.
Everyone should do their own research in regards value, but the assumptions in these reports can be very helpful when building your own valuation models.
On a personal note, I don’t think I have ever read an analyst report with more conservative assumptions than this one.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.015(1.22%) |
Mkt cap ! $215.4M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.23 | $106.2K | 85.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 11900 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 819 | 1 |
View Market Depth
| Last trade - 15.56pm 26/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |